| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 3.69e-10 | 4 | 89 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 3.69e-10 | 4 | 89 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 3.69e-10 | 4 | 89 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.84e-09 | 5 | 89 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.84e-09 | 5 | 89 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.84e-09 | 5 | 89 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 5.49e-09 | 6 | 89 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.28e-08 | 7 | 89 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.55e-08 | 8 | 89 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.55e-08 | 8 | 89 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.55e-08 | 8 | 89 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 4.57e-08 | 9 | 89 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 4.57e-08 | 9 | 89 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 7.59e-08 | 10 | 89 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 7.59e-08 | 10 | 89 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.57e-07 | 14 | 89 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.57e-07 | 14 | 89 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.69e-06 | 20 | 89 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 3.66e-06 | 24 | 89 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 5.11e-06 | 26 | 89 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 5.11e-06 | 26 | 89 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 5.98e-06 | 27 | 89 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 9.25e-06 | 30 | 89 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.21e-05 | 32 | 89 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.37e-05 | 33 | 89 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.38e-05 | 11 | 89 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.54e-05 | 34 | 89 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.69e-05 | 39 | 89 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | lipid binding | SEC14L3 PSAP SEC14L6 PLA2G4B CYTH2 AKR1C3 MYO1B AKR1C4 CPS1 ACBD6 SEC14L4 AKR1C1 AKR1C2 PXK SEC14L2 | 2.88e-05 | 988 | 89 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.98e-05 | 40 | 89 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 6.18e-05 | 48 | 89 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.13e-04 | 56 | 89 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.17e-04 | 107 | 89 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.17e-04 | 4 | 89 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.49e-04 | 60 | 89 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 1.69e-04 | 62 | 89 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 1.69e-04 | 62 | 89 | 4 | GO:0050661 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 4.24e-04 | 33 | 89 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 6.93e-04 | 9 | 89 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 6.93e-04 | 9 | 89 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 7.01e-04 | 239 | 89 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 8.62e-04 | 95 | 89 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | organic acid binding | 9.61e-04 | 254 | 89 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.26e-03 | 12 | 89 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.75e-03 | 115 | 89 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.76e-03 | 194 | 89 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.51e-03 | 127 | 89 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | steroid binding | 2.97e-03 | 133 | 89 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 2.97e-03 | 938 | 89 | 11 | GO:0016772 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 3.39e-03 | 138 | 89 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 3.54e-03 | 20 | 89 | 2 | GO:0035259 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 2.69e-10 | 4 | 85 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 2.69e-10 | 4 | 85 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 2.69e-10 | 4 | 85 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 2.69e-10 | 4 | 85 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 1.34e-09 | 5 | 85 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 1.34e-09 | 5 | 85 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 1.34e-09 | 5 | 85 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 1.34e-09 | 5 | 85 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 1.34e-09 | 5 | 85 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 1.34e-09 | 5 | 85 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 4.00e-09 | 6 | 85 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 4.00e-09 | 6 | 85 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 9.31e-09 | 7 | 85 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 9.31e-09 | 7 | 85 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 9.31e-09 | 7 | 85 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | parturition | 2.63e-08 | 22 | 85 | 5 | GO:0007567 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 3.33e-08 | 9 | 85 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 5.53e-08 | 10 | 85 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 5.53e-08 | 10 | 85 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 5.53e-08 | 10 | 85 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 5.53e-08 | 10 | 85 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 5.53e-08 | 10 | 85 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 8.67e-08 | 11 | 85 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 8.67e-08 | 11 | 85 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 2.61e-07 | 14 | 85 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 2.61e-07 | 14 | 85 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 3.54e-07 | 15 | 85 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 4.71e-07 | 16 | 85 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 4.71e-07 | 16 | 85 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 7.86e-07 | 18 | 85 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 7.96e-07 | 42 | 85 | 5 | GO:0071398 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 1.42e-06 | 135 | 85 | 7 | GO:0019218 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.52e-06 | 21 | 85 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 1.52e-06 | 21 | 85 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 1.52e-06 | 21 | 85 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.52e-06 | 21 | 85 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.52e-06 | 21 | 85 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 1.86e-06 | 22 | 85 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 1.86e-06 | 22 | 85 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.86e-06 | 22 | 85 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 2.24e-06 | 23 | 85 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.24e-06 | 23 | 85 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 3.75e-06 | 26 | 85 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.05e-06 | 158 | 85 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 5.03e-06 | 106 | 85 | 6 | GO:0050810 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 5.10e-06 | 28 | 85 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 5.90e-06 | 29 | 85 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 5.90e-06 | 29 | 85 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | AKR1C3 BIRC2 OAS3 AKR1C4 PIAS2 ZDHHC3 AKR1C1 AKR1C2 KDM1A EPG5 | 8.13e-06 | 416 | 85 | 10 | GO:0030522 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 8.34e-06 | 67 | 85 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 8.84e-06 | 32 | 85 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 9.64e-06 | 69 | 85 | 5 | GO:0070542 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 1.00e-05 | 33 | 85 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.01e-05 | 336 | 85 | 9 | GO:0071560 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.13e-05 | 34 | 85 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.19e-05 | 343 | 85 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.28e-05 | 35 | 85 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 1.36e-05 | 74 | 85 | 5 | GO:2000351 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.43e-05 | 36 | 85 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 1.43e-05 | 36 | 85 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 1.78e-05 | 38 | 85 | 4 | GO:0048384 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 1.87e-05 | 79 | 85 | 5 | GO:0072577 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.19e-05 | 40 | 85 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 2.78e-05 | 382 | 85 | 9 | GO:0016042 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 3.52e-05 | 45 | 85 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.19e-05 | 47 | 85 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 8.38e-05 | 56 | 85 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 8.98e-05 | 57 | 85 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 8.98e-05 | 57 | 85 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 9.62e-05 | 58 | 85 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 1.10e-04 | 60 | 85 | 4 | GO:1904037 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.15e-04 | 358 | 85 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.15e-04 | 358 | 85 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.24e-04 | 362 | 85 | 8 | GO:0000375 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 1.88e-04 | 128 | 85 | 5 | GO:0033559 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.88e-04 | 202 | 85 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.95e-04 | 129 | 85 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 2.26e-04 | 209 | 85 | 6 | GO:0006694 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.35e-04 | 73 | 85 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 3.04e-04 | 142 | 85 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | 3.13e-04 | 415 | 85 | 8 | GO:0019216 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 3.51e-04 | 81 | 85 | 4 | GO:0071384 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 3.79e-04 | 149 | 85 | 5 | GO:0062014 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell apoptotic process | 4.15e-04 | 152 | 85 | 5 | GO:1904035 | |
| GeneOntologyBiologicalProcess | mRNA processing | 4.40e-04 | 551 | 85 | 9 | GO:0006397 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 4.63e-04 | 239 | 85 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 4.81e-04 | 88 | 85 | 4 | GO:0071277 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 5.02e-04 | 89 | 85 | 4 | GO:2000379 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 5.02e-04 | 89 | 85 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 5.17e-04 | 244 | 85 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 5.40e-04 | 246 | 85 | 6 | GO:0046890 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 5.46e-04 | 91 | 85 | 4 | GO:0051055 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 6.18e-04 | 94 | 85 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 6.43e-04 | 95 | 85 | 4 | GO:0006081 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 6.69e-04 | 96 | 85 | 4 | GO:1901657 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | SLIT2 FBN2 AKR1C3 AKR1C4 LTBP3 CPS1 USP9Y CDH5 AKR1C1 AKR1C2 SMAD3 | 7.20e-04 | 850 | 85 | 11 | GO:0071363 |
| GeneOntologyBiologicalProcess | response to estrogen | 8.71e-04 | 103 | 85 | 4 | GO:0043627 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 8.94e-04 | 180 | 85 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 9.22e-04 | 376 | 85 | 7 | GO:0008202 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 9.36e-04 | 105 | 85 | 4 | GO:0006721 | |
| MousePheno | parturition failure | 1.25e-07 | 10 | 71 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 1.96e-07 | 11 | 71 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 4.22e-07 | 13 | 71 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 7.99e-07 | 15 | 71 | 4 | MP:0005186 | |
| MousePheno | long stride length | 7.99e-07 | 15 | 71 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 7.99e-07 | 15 | 71 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 1.77e-06 | 18 | 71 | 4 | MP:0002292 | |
| MousePheno | dysmyelination | 2.78e-06 | 20 | 71 | 4 | MP:0013438 | |
| MousePheno | abnormal oligodendrocyte morphology | 5.74e-06 | 51 | 71 | 5 | MP:0000953 | |
| MousePheno | decreased oligodendrocyte number | 7.13e-06 | 25 | 71 | 4 | MP:0009808 | |
| MousePheno | prolonged diestrus | 1.52e-05 | 30 | 71 | 4 | MP:0009011 | |
| MousePheno | abnormal myelination | 2.06e-05 | 166 | 71 | 7 | MP:0000920 | |
| MousePheno | abnormal parturition | 2.24e-05 | 33 | 71 | 4 | MP:0002907 | |
| MousePheno | abnormal diestrus | 2.84e-05 | 35 | 71 | 4 | MP:0009010 | |
| MousePheno | enhanced coordination | 3.96e-05 | 38 | 71 | 4 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 4.39e-05 | 39 | 71 | 4 | MP:0009006 | |
| MousePheno | abnormal stride length | 5.90e-05 | 82 | 71 | 5 | MP:0012690 | |
| MousePheno | decreased vocalization | 8.49e-05 | 46 | 71 | 4 | MP:0020351 | |
| MousePheno | stereotypic behavior | 1.04e-04 | 214 | 71 | 7 | MP:0001408 | |
| MousePheno | abnormal circulating progesterone level | 1.18e-04 | 50 | 71 | 4 | MP:0005184 | |
| MousePheno | increased stereotypic behavior | 1.48e-04 | 53 | 71 | 4 | MP:0001409 | |
| MousePheno | abnormal progesterone level | 1.60e-04 | 54 | 71 | 4 | MP:0011384 | |
| MousePheno | abnormal glial cell morphology | 3.49e-04 | 345 | 71 | 8 | MP:0003634 | |
| MousePheno | abnormal estrous cycle | 3.55e-04 | 120 | 71 | 5 | MP:0001927 | |
| MousePheno | increased erythrocyte cell number | 3.98e-04 | 123 | 71 | 5 | MP:0003131 | |
| MousePheno | abnormal ovulation cycle | 4.45e-04 | 126 | 71 | 5 | MP:0009344 | |
| MousePheno | abnormal CNS glial cell morphology | 4.49e-04 | 272 | 71 | 7 | MP:0000952 | |
| Domain | ALDOKETO_REDUCTASE_1 | 9.90e-08 | 10 | 89 | 4 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 9.90e-08 | 10 | 89 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 9.90e-08 | 10 | 89 | 4 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 9.90e-08 | 10 | 89 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 9.90e-08 | 10 | 89 | 4 | PS00063 | |
| Domain | CRAL-bd_toc_tran | 2.32e-07 | 12 | 89 | 4 | IPR001071 | |
| Domain | CRAL_TRIO_N | 2.32e-07 | 12 | 89 | 4 | SM01100 | |
| Domain | CRAL/TRIO_N_dom | 6.32e-07 | 15 | 89 | 4 | IPR011074 | |
| Domain | - | 8.39e-07 | 16 | 89 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.09e-06 | 17 | 89 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 1.09e-06 | 17 | 89 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.09e-06 | 17 | 89 | 4 | IPR001395 | |
| Domain | GOLD_dom | 1.77e-06 | 19 | 89 | 4 | IPR009038 | |
| Domain | GOLD | 1.77e-06 | 19 | 89 | 4 | PS50866 | |
| Domain | CRAL_TRIO | 2.71e-06 | 21 | 89 | 4 | PF00650 | |
| Domain | - | 3.98e-06 | 23 | 89 | 4 | 3.40.525.10 | |
| Domain | SEC14 | 5.64e-06 | 25 | 89 | 4 | SM00516 | |
| Domain | CRAL_TRIO | 7.77e-06 | 27 | 89 | 4 | PS50191 | |
| Domain | CRAL-TRIO_dom | 9.04e-06 | 28 | 89 | 4 | IPR001251 | |
| Domain | CRAL_TRIO_N | 1.68e-05 | 11 | 89 | 3 | PF03765 | |
| Domain | FAM76 | 2.25e-05 | 2 | 89 | 2 | IPR032017 | |
| Domain | FAM76 | 2.25e-05 | 2 | 89 | 2 | PF16046 | |
| Domain | EMP24_GP25L | 4.57e-05 | 15 | 89 | 3 | PF01105 | |
| Domain | hEGF | 3.14e-04 | 28 | 89 | 3 | PF12661 | |
| Domain | TB | 4.64e-04 | 7 | 89 | 2 | PF00683 | |
| Domain | - | 6.17e-04 | 8 | 89 | 2 | 3.90.290.10 | |
| Domain | TB | 7.91e-04 | 9 | 89 | 2 | PS51364 | |
| Domain | TB_dom | 7.91e-04 | 9 | 89 | 2 | IPR017878 | |
| Domain | NTP_transf_2 | 1.20e-03 | 11 | 89 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 1.20e-03 | 11 | 89 | 2 | IPR002934 | |
| Domain | Tumour_necrosis_fac-like_dom | 2.67e-03 | 58 | 89 | 3 | IPR008983 | |
| Domain | - | 4.03e-03 | 20 | 89 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 4.45e-03 | 21 | 89 | 2 | IPR003594 | |
| Domain | ARM-type_fold | 5.63e-03 | 339 | 89 | 6 | IPR016024 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 4.79e-08 | 9 | 64 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 4.79e-08 | 9 | 64 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.24e-07 | 11 | 64 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.68e-07 | 13 | 64 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.68e-07 | 13 | 64 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 3.74e-07 | 14 | 64 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.74e-07 | 14 | 64 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 3.74e-07 | 14 | 64 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.74e-07 | 14 | 64 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 5.08e-07 | 15 | 64 | 4 | MM14870 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 3.21e-06 | 23 | 64 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.21e-06 | 23 | 64 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 3.21e-06 | 23 | 64 | 4 | MM14741 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 7.29e-06 | 28 | 64 | 4 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 1.43e-05 | 33 | 64 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 1.43e-05 | 33 | 64 | 4 | MM14737 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 4.58e-05 | 44 | 64 | 4 | M499 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 5.01e-05 | 45 | 64 | 4 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 5.01e-05 | 45 | 64 | 4 | MM14751 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 7.02e-05 | 49 | 64 | 4 | MM15186 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.11e-04 | 55 | 64 | 4 | M14933 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.66e-04 | 61 | 64 | 4 | MM14861 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.83e-04 | 70 | 64 | 4 | M16794 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 8.00e-04 | 92 | 64 | 4 | MM14881 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.03e-03 | 170 | 64 | 5 | MM15573 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.03e-03 | 44 | 64 | 3 | M875 | |
| Pathway | WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS | 1.09e-03 | 11 | 64 | 2 | M39749 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 1.11e-03 | 45 | 64 | 3 | M39355 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.33e-03 | 48 | 64 | 3 | M27642 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.73e-03 | 191 | 64 | 5 | MM15586 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 4.38e-11 | 4 | 91 | 4 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 4.38e-11 | 4 | 91 | 4 | 16508162 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 4.38e-11 | 4 | 91 | 4 | 14967952 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 4.38e-11 | 4 | 91 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 4.38e-11 | 4 | 91 | 4 | 31479646 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 15222881 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 16191478 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 15577209 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 10702227 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 17034817 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 4.38e-11 | 4 | 91 | 4 | 29764944 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 10526179 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 17888864 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 17442338 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 28329705 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 16018803 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 17272929 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 4.38e-11 | 4 | 91 | 4 | 18667791 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 28259989 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 21521174 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 8274401 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 16511129 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 4.38e-11 | 4 | 91 | 4 | 34590152 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 7789999 | ||
| Pubmed | 2.19e-10 | 5 | 91 | 4 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.19e-10 | 5 | 91 | 4 | 21851338 | |
| Pubmed | 2.19e-10 | 5 | 91 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.19e-10 | 5 | 91 | 4 | 17064890 | |
| Pubmed | 2.19e-10 | 5 | 91 | 4 | 10672042 | ||
| Pubmed | 2.19e-10 | 5 | 91 | 4 | 38788959 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.19e-10 | 5 | 91 | 4 | 16984997 | |
| Pubmed | 2.19e-10 | 5 | 91 | 4 | 18003893 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 6.55e-10 | 6 | 91 | 4 | 29107092 | |
| Pubmed | 6.55e-10 | 6 | 91 | 4 | 19273550 | ||
| Pubmed | 6.55e-10 | 6 | 91 | 4 | 15860270 | ||
| Pubmed | 6.55e-10 | 6 | 91 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 6.55e-10 | 6 | 91 | 4 | 26748576 | |
| Pubmed | 6.55e-10 | 6 | 91 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 6.55e-10 | 6 | 91 | 4 | 17255200 | |
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 1.24e-09 | 19 | 91 | 5 | 17599069 | |
| Pubmed | 1.53e-09 | 7 | 91 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 1.53e-09 | 7 | 91 | 4 | 34843575 | |
| Pubmed | 1.53e-09 | 7 | 91 | 4 | 22529366 | ||
| Pubmed | 1.53e-09 | 7 | 91 | 4 | 33127481 | ||
| Pubmed | 1.53e-09 | 7 | 91 | 4 | 12562828 | ||
| Pubmed | 1.53e-09 | 7 | 91 | 4 | 16337335 | ||
| Pubmed | 3.04e-09 | 8 | 91 | 4 | 33584538 | ||
| Pubmed | 3.04e-09 | 8 | 91 | 4 | 20837989 | ||
| Pubmed | 3.04e-09 | 8 | 91 | 4 | 9224647 | ||
| Pubmed | 5.47e-09 | 9 | 91 | 4 | 33348080 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 6.91e-09 | 26 | 91 | 5 | 23892084 | |
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 8.46e-09 | 27 | 91 | 5 | 14581517 | |
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 9.10e-09 | 10 | 91 | 4 | 36313771 | |
| Pubmed | 1.73e-08 | 3 | 91 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 1.73e-08 | 3 | 91 | 3 | 31780644 | |
| Pubmed | 1.73e-08 | 3 | 91 | 3 | 7626489 | ||
| Pubmed | 1.73e-08 | 3 | 91 | 3 | 21232532 | ||
| Pubmed | 1.73e-08 | 3 | 91 | 3 | 13678667 | ||
| Pubmed | 1.73e-08 | 3 | 91 | 3 | 15033454 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 2.14e-08 | 12 | 91 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 2.14e-08 | 12 | 91 | 4 | 28893949 | |
| Pubmed | 2.14e-08 | 12 | 91 | 4 | 25774556 | ||
| Pubmed | 3.08e-08 | 13 | 91 | 4 | 11682476 | ||
| Pubmed | 3.08e-08 | 13 | 91 | 4 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 3.08e-08 | 13 | 91 | 4 | 15117747 | |
| Pubmed | 3.08e-08 | 13 | 91 | 4 | 24580729 | ||
| Pubmed | 4.30e-08 | 14 | 91 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 4.30e-08 | 14 | 91 | 4 | 34400844 | |
| Pubmed | 6.92e-08 | 4 | 91 | 3 | 17077281 | ||
| Pubmed | Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. | 6.92e-08 | 4 | 91 | 3 | 12757856 | |
| Pubmed | 1.02e-07 | 17 | 91 | 4 | 32243503 | ||
| Pubmed | 1.73e-07 | 5 | 91 | 3 | 17428729 | ||
| Pubmed | 1.73e-07 | 5 | 91 | 3 | 15212687 | ||
| Pubmed | 2.06e-07 | 20 | 91 | 4 | 23636947 | ||
| Pubmed | 2.06e-07 | 20 | 91 | 4 | 24135228 | ||
| Pubmed | 3.74e-07 | 23 | 91 | 4 | 23685333 | ||
| Pubmed | 5.32e-07 | 25 | 91 | 4 | 26098214 | ||
| Pubmed | 6.02e-07 | 7 | 91 | 3 | 19846565 | ||
| Pubmed | 7.35e-07 | 27 | 91 | 4 | 17077188 | ||
| Pubmed | 7.35e-07 | 27 | 91 | 4 | 23471215 | ||
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 8.56e-07 | 28 | 91 | 4 | 29879378 | |
| Pubmed | 8.56e-07 | 28 | 91 | 4 | 21820362 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 8.56e-07 | 28 | 91 | 4 | 29212953 | |
| Pubmed | 1.49e-06 | 32 | 91 | 4 | 34288113 | ||
| Pubmed | 2.71e-06 | 37 | 91 | 4 | 21362171 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 APEX2 CDK11A ANP32E MYO1B DDX20 HUWE1 PIAS2 KDM1A RPAP2 | 3.33e-06 | 588 | 91 | 10 | 38580884 |
| Pubmed | WT1-mediated gene regulation in early urogenital ridge development. | 6.02e-06 | 45 | 91 | 4 | 18391535 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 6.10e-06 | 171 | 91 | 6 | 20201926 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 8172617 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 8573067 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 7650035 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 11514561 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15492289 | ||
| Pubmed | Local androgen inactivation in abdominal visceral adipose tissue. | 6.77e-06 | 2 | 91 | 2 | 14671194 | |
| Interaction | AKR1C4 interactions | 2.34e-08 | 8 | 88 | 4 | int:AKR1C4 | |
| Interaction | AKR1C1 interactions | 1.56e-06 | 20 | 88 | 4 | int:AKR1C1 | |
| Interaction | SEC14L3 interactions | 1.59e-06 | 6 | 88 | 3 | int:SEC14L3 | |
| Interaction | AKR1C3 interactions | 2.01e-05 | 37 | 88 | 4 | int:AKR1C3 | |
| Cytoband | 10p15-p14 | 1.50e-07 | 6 | 91 | 3 | 10p15-p14 | |
| Cytoband | 22q12.2 | 5.65e-06 | 58 | 91 | 4 | 22q12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 3.24e-05 | 90 | 91 | 4 | chr10p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 1.26e-03 | 235 | 91 | 4 | chr22q12 | |
| Cytoband | 4p15.2 | 1.42e-03 | 28 | 91 | 2 | 4p15.2 | |
| GeneFamily | SEC14 family|PRELI domain containing | 9.09e-10 | 6 | 52 | 4 | 1063 | |
| GeneFamily | Aldo-keto reductases | 8.11e-08 | 15 | 52 | 4 | 399 | |
| GeneFamily | Phospholipases | 2.38e-04 | 42 | 52 | 3 | 467 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.34e-03 | 19 | 52 | 2 | 832 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 2.99e-07 | 17 | 90 | 4 | MM826 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 1.31e-06 | 24 | 90 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.56e-06 | 25 | 90 | 4 | MM480 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 3.33e-06 | 30 | 90 | 4 | MM853 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 5.70e-06 | 74 | 90 | 5 | MM769 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 7.04e-06 | 36 | 90 | 4 | MM3660 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 7.87e-06 | 37 | 90 | 4 | MM630 | |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 1.13e-05 | 85 | 90 | 5 | MM802 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 1.74e-05 | 45 | 90 | 4 | MM1173 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 4.11e-05 | 111 | 90 | 5 | MM705 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 5.47e-05 | 60 | 90 | 4 | MM847 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | 6.87e-05 | 293 | 90 | 7 | MM895 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 7.96e-05 | 66 | 90 | 4 | MM631 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 9.47e-05 | 69 | 90 | 4 | MM621 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 1.21e-04 | 28 | 90 | 3 | MM1323 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 1.37e-04 | 228 | 90 | 6 | MM1014 | |
| Coexpression | FRASOR_RESPONSE_TO_ESTRADIOL_DN | 1.53e-04 | 78 | 90 | 4 | M3002 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 1.60e-04 | 79 | 90 | 4 | MM535 | |
| Coexpression | LI_ESTROGENE_LATE_E2_RESPONSE_DN | 1.68e-04 | 80 | 90 | 4 | M48218 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 2.05e-04 | 156 | 90 | 5 | MM550 | |
| CoexpressionAtlas | liver | ADRA1A AKR1C4 CFHR5 ACMSD CPS1 USH2A SEC14L4 AKR1C2 ABCC6 SEC14L2 | 1.13e-05 | 419 | 90 | 10 | liver |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-08 | 160 | 90 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-08 | 160 | 90 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 7.52e-06 | 133 | 90 | 5 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-05 | 152 | 90 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-05 | 152 | 90 | 5 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-05 | 157 | 90 | 5 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 164 | 90 | 5 | 583dda853cee9491dbdcb228c23d8deadc20eb08 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 165 | 90 | 5 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 172 | 90 | 5 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 175 | 90 | 5 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.83e-05 | 175 | 90 | 5 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | BAL-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 2.99e-05 | 177 | 90 | 5 | aa021f6d62e9d740c5ea499faaf875de835a2865 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 179 | 90 | 5 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 179 | 90 | 5 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 179 | 90 | 5 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-05 | 181 | 90 | 5 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.32e-05 | 181 | 90 | 5 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-05 | 181 | 90 | 5 | 9842537f9a607d8557c43790008d175edab1f32c | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.41e-05 | 182 | 90 | 5 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 183 | 90 | 5 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 184 | 90 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 184 | 90 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 184 | 90 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.59e-05 | 184 | 90 | 5 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 185 | 90 | 5 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.78e-05 | 186 | 90 | 5 | 86d145f965c311189e7996390eef491642417c5c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.78e-05 | 186 | 90 | 5 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 186 | 90 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.78e-05 | 186 | 90 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 186 | 90 | 5 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-05 | 187 | 90 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 187 | 90 | 5 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 187 | 90 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-05 | 187 | 90 | 5 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 187 | 90 | 5 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-05 | 188 | 90 | 5 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-05 | 188 | 90 | 5 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-05 | 188 | 90 | 5 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.98e-05 | 188 | 90 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-05 | 189 | 90 | 5 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-05 | 190 | 90 | 5 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-05 | 191 | 90 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-05 | 191 | 90 | 5 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-05 | 192 | 90 | 5 | 5d24bb6c6c17a6b803b241d065b31896a7d86c37 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.40e-05 | 192 | 90 | 5 | c6795ceba90f1a5d441dff92a737b9c7d28b06b0 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 4.74e-05 | 195 | 90 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-05 | 196 | 90 | 5 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.85e-05 | 196 | 90 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-05 | 197 | 90 | 5 | a41420d4b6d502c2f594c054c7efbb5d4eac83ff | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-05 | 197 | 90 | 5 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.97e-05 | 197 | 90 | 5 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 4.97e-05 | 197 | 90 | 5 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.09e-05 | 198 | 90 | 5 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.09e-05 | 198 | 90 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.09e-05 | 198 | 90 | 5 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-05 | 199 | 90 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-04 | 124 | 90 | 4 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 134 | 90 | 4 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 138 | 90 | 4 | 2e46d546ad962aa0fde5b1c18c2a5370a4424e9f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.97e-04 | 142 | 90 | 4 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 144 | 90 | 4 | cc11cce43d1af8ac63140d05faf215ae9a10cde1 | |
| ToppCell | BAL-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 2.13e-04 | 145 | 90 | 4 | 3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 145 | 90 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.31e-04 | 148 | 90 | 4 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-04 | 149 | 90 | 4 | cc911b454fe4e4b489885b9920baa7eb01a027ba | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 150 | 90 | 4 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.89e-04 | 157 | 90 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.03e-04 | 159 | 90 | 4 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-04 | 162 | 90 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 3.33e-04 | 163 | 90 | 4 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.33e-04 | 163 | 90 | 4 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.33e-04 | 163 | 90 | 4 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.41e-04 | 164 | 90 | 4 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 164 | 90 | 4 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.41e-04 | 164 | 90 | 4 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-04 | 165 | 90 | 4 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-04 | 166 | 90 | 4 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-04 | 166 | 90 | 4 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 166 | 90 | 4 | 21ba5fd755c0fb31ada42a1b5d60bede0153323d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-04 | 167 | 90 | 4 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Syt6-Excitatory_NeuronSlc17a7-Slc17a6.Syt6-Nnat_(Deep_layer_pyramidal_cells--medial_cortex)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.69e-04 | 69 | 90 | 3 | de297aa59c70f15c55cb9570439dc6d3fd6c182b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.69e-04 | 69 | 90 | 3 | 31f4fb56dfa5e3ad7c83e0770960c3617e4f66a7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 168 | 90 | 4 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 168 | 90 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 169 | 90 | 4 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-04 | 169 | 90 | 4 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.82e-04 | 169 | 90 | 4 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.82e-04 | 169 | 90 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 169 | 90 | 4 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.90e-04 | 170 | 90 | 4 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| Drug | Pregnanes | 2.08e-10 | 4 | 88 | 4 | ctd:D011278 | |
| Drug | tetralol | 2.08e-10 | 4 | 88 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 2.08e-10 | 4 | 88 | 4 | ctd:C018156 | |
| Drug | cloxazolam | 2.08e-10 | 4 | 88 | 4 | ctd:C005522 | |
| Drug | Hydroxysteroids | 1.04e-09 | 5 | 88 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 1.04e-09 | 5 | 88 | 4 | ctd:C010092 | |
| Drug | Medazepam | 3.11e-09 | 6 | 88 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 1.44e-08 | 8 | 88 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 2.59e-08 | 9 | 88 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 2.59e-08 | 9 | 88 | 4 | ctd:D004092 | |
| Drug | octyl gallate | 4.30e-08 | 10 | 88 | 4 | ctd:C016627 | |
| Drug | cyclopentanone | 5.58e-08 | 3 | 88 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 5.58e-08 | 3 | 88 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 5.58e-08 | 3 | 88 | 3 | ctd:C058818 | |
| Drug | cyclopentanol | 5.58e-08 | 3 | 88 | 3 | ctd:C016327 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 5.58e-08 | 3 | 88 | 3 | ctd:C530610 | |
| Drug | Dihydroxydihydrobenzopyrenes | 6.73e-08 | 11 | 88 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 6.73e-08 | 11 | 88 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 1.01e-07 | 12 | 88 | 4 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 1.45e-07 | 13 | 88 | 4 | CID000050096 | |
| Drug | flunisolide | 1.45e-07 | 13 | 88 | 4 | ctd:C007734 | |
| Drug | 1-acenaphthenol | 2.02e-07 | 14 | 88 | 4 | CID000022750 | |
| Drug | 5-alpha-Dihydroprogesterone | 2.02e-07 | 14 | 88 | 4 | ctd:D043582 | |
| Drug | Meclofenamic Acid | 2.02e-07 | 14 | 88 | 4 | ctd:D008469 | |
| Drug | tetrahydrodeoxycorticosterone | 2.23e-07 | 4 | 88 | 3 | ctd:C009413 | |
| Drug | gliquidone | 2.23e-07 | 4 | 88 | 3 | ctd:C010969 | |
| Drug | DBD-H | 2.23e-07 | 4 | 88 | 3 | CID000131382 | |
| Drug | NSC86000 | 5.55e-07 | 5 | 88 | 3 | CID000257630 | |
| Drug | oxcarbazepine | 7.72e-07 | 19 | 88 | 4 | ctd:C036006 | |
| Drug | benzo(a)pyrene-7,8-dione | 9.63e-07 | 20 | 88 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 9.63e-07 | 20 | 88 | 4 | ctd:D002911 | |
| Drug | AC1L93E5 | 1.11e-06 | 6 | 88 | 3 | CID000412383 | |
| Drug | acenaphthene-1-ol | 1.11e-06 | 6 | 88 | 3 | ctd:C023723 | |
| Drug | Estazolam | 1.11e-06 | 6 | 88 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 1.11e-06 | 6 | 88 | 3 | CID000439898 | |
| Drug | Glipizide | 1.11e-06 | 6 | 88 | 3 | ctd:D005913 | |
| Drug | Flunitrazepam | 1.19e-06 | 21 | 88 | 4 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 1.44e-06 | 22 | 88 | 4 | CID000000418 | |
| Drug | 4-hydroxyequilenin-o-quinone | 1.93e-06 | 7 | 88 | 3 | ctd:C117714 | |
| Drug | zomepirac | 1.93e-06 | 7 | 88 | 3 | ctd:C020549 | |
| Drug | Glycyrrhetinic Acid | 2.09e-06 | 24 | 88 | 4 | ctd:D006034 | |
| Drug | Pregnanolone | 2.48e-06 | 25 | 88 | 4 | ctd:D011280 | |
| Drug | 9,10-phenanthrenequinone | 2.48e-06 | 25 | 88 | 4 | ctd:C005399 | |
| Drug | 2-cyclohexen-1-ol | 3.08e-06 | 8 | 88 | 3 | CID000013198 | |
| Drug | 3,4-dichloroaniline | 4.54e-06 | 171 | 88 | 7 | ctd:C014464 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 6.05e-06 | 31 | 88 | 4 | ctd:C017228 | |
| Drug | Vitamin E | 6.57e-06 | 10 | 88 | 3 | DB00163 | |
| Drug | fenamic acid | 1.20e-05 | 12 | 88 | 3 | ctd:C001209 | |
| Drug | alpha-methylcinnamic acid | 1.48e-05 | 2 | 88 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.48e-05 | 2 | 88 | 2 | DB07768 | |
| Drug | baccharin | 1.48e-05 | 2 | 88 | 2 | ctd:C012764 | |
| Drug | 4-formyl-benzoate | 1.55e-05 | 13 | 88 | 3 | CID000012088 | |
| Drug | 20 alpha-dihydroprogesterone | 1.71e-05 | 40 | 88 | 4 | CID000008956 | |
| Drug | o-quinone | 1.89e-05 | 41 | 88 | 4 | CID000011421 | |
| Drug | Dydrogesterone | 1.97e-05 | 14 | 88 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 1.97e-05 | 14 | 88 | 3 | CID000631219 | |
| Drug | drospirenone | 2.45e-05 | 15 | 88 | 3 | ctd:C035144 | |
| Drug | Flufenamic Acid | 2.75e-05 | 45 | 88 | 4 | ctd:D005439 | |
| Drug | naphthalene-1,2-dihydrodiol | 2.75e-05 | 45 | 88 | 4 | CID000000362 | |
| Drug | caffeic acid phenethyl ester | 2.76e-05 | 311 | 88 | 8 | ctd:C055494 | |
| Drug | 9-cis-retinal | 3.01e-05 | 16 | 88 | 3 | ctd:C031390 | |
| Drug | 2-nitrobenzaldehyde | 3.01e-05 | 16 | 88 | 3 | CID000011101 | |
| Drug | Octa | 3.56e-05 | 48 | 88 | 4 | CID000010213 | |
| Drug | benzo(a)pyrene-1,6-quinone | 3.65e-05 | 17 | 88 | 3 | ctd:C030233 | |
| Drug | cloxazolam | 4.37e-05 | 18 | 88 | 3 | CID000002816 | |
| Drug | benzo(a)pyrene-3,6-quinone | 4.37e-05 | 18 | 88 | 3 | ctd:C018003 | |
| Drug | Ruthenium Compounds | 4.37e-05 | 18 | 88 | 3 | ctd:D017975 | |
| Drug | androstane-3,17-dione | 4.53e-05 | 51 | 88 | 4 | CID000000443 | |
| Drug | AC1L8ZBW | 5.17e-05 | 19 | 88 | 3 | CID000435356 | |
| Drug | Hexestrol | 6.11e-05 | 55 | 88 | 4 | ctd:D006589 | |
| Drug | 1,2-dihydroxynaphthalene | 7.04e-05 | 57 | 88 | 4 | CID000011318 | |
| Drug | coniferaldehyde | 7.06e-05 | 21 | 88 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 7.06e-05 | 21 | 88 | 3 | ctd:D000068538 | |
| Drug | phenolphthalein | 7.54e-05 | 58 | 88 | 4 | CID000004764 | |
| Drug | NSC36919 | 7.54e-05 | 58 | 88 | 4 | CID000235496 | |
| Drug | Salmfamide 1 | 8.82e-05 | 4 | 88 | 2 | CID005487416 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 9.31e-05 | 189 | 88 | 6 | 7002_UP | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 9.34e-05 | 23 | 88 | 3 | DB03461 | |
| Drug | medazepam | 1.06e-04 | 24 | 88 | 3 | CID000004041 | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; HL60; HT_HG-U133A | 1.07e-04 | 194 | 88 | 6 | 2527_UP | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 7403_UP | |
| Drug | chlordecone | 1.33e-04 | 67 | 88 | 4 | CID000000299 | |
| Drug | glycolithocholic acid | 1.36e-04 | 26 | 88 | 3 | CID000115245 | |
| Drug | farnesal | 1.47e-04 | 5 | 88 | 2 | ctd:C084519 | |
| Drug | 5 beta-pregnane-3,20-dione | 1.75e-04 | 72 | 88 | 4 | CID000092745 | |
| Drug | Diazepam | 1.95e-04 | 74 | 88 | 4 | ctd:D003975 | |
| Drug | AC1NBT2J | 2.55e-04 | 32 | 88 | 3 | CID003958805 | |
| Drug | NAD | 2.63e-04 | 80 | 88 | 4 | ctd:D009243 | |
| Drug | Budesonide | 2.63e-04 | 80 | 88 | 4 | ctd:D019819 | |
| Drug | 1,10-phenanthroline | 2.90e-04 | 82 | 88 | 4 | ctd:C025205 | |
| Drug | tetrahydrozoline | 3.06e-04 | 7 | 88 | 2 | CID000005419 | |
| Drug | estazolam | 3.34e-04 | 35 | 88 | 3 | CID000003261 | |
| Drug | quercitrin | 3.63e-04 | 36 | 88 | 3 | CID005280459 | |
| Disease | Neoplasms, Hormone-Dependent | 2.48e-08 | 3 | 87 | 3 | C0027661 | |
| Disease | Ambiguous Genitalia | 2.47e-07 | 5 | 87 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.47e-07 | 5 | 87 | 3 | C0033804 | |
| Disease | Hermaphroditism | 2.47e-07 | 5 | 87 | 3 | C0019269 | |
| Disease | Intersex Conditions | 2.47e-07 | 5 | 87 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.47e-07 | 5 | 87 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 8.59e-07 | 7 | 87 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 8.59e-06 | 2 | 87 | 2 | C1839840 | |
| Disease | laryngeal squamous cell carcinoma, hypopharynx cancer | 8.59e-06 | 2 | 87 | 2 | EFO_0006352, EFO_0007321 | |
| Disease | 46,XY SEX REVERSAL 8 | 8.59e-06 | 2 | 87 | 2 | 614279 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 8.59e-06 | 2 | 87 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 8.59e-06 | 2 | 87 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | cortolone glucuronide (1) measurement | 1.28e-04 | 6 | 87 | 2 | EFO_0800552 | |
| Disease | Degenerative polyarthritis | 1.69e-04 | 93 | 87 | 4 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 1.69e-04 | 93 | 87 | 4 | C0086743 | |
| Disease | Prostatic Cancer, Castration-Resistant | 3.05e-04 | 9 | 87 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 3.05e-04 | 9 | 87 | 2 | C3658267 | |
| Disease | free androgen index | 8.49e-04 | 374 | 87 | 6 | EFO_0007005 | |
| Disease | response to methotrexate | 1.00e-03 | 16 | 87 | 2 | GO_0031427 | |
| Disease | triacylglycerol 50:5 measurement | 1.00e-03 | 16 | 87 | 2 | EFO_0010412 | |
| Disease | Endometrial Carcinoma | 1.27e-03 | 72 | 87 | 3 | C0476089 | |
| Disease | alpha-tocopherol measurement | 1.58e-03 | 20 | 87 | 2 | EFO_0007898 | |
| Disease | Osteoarthritis of hip | 1.58e-03 | 20 | 87 | 2 | C0029410 | |
| Disease | Left Ventricle Remodeling | 1.74e-03 | 21 | 87 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 1.74e-03 | 21 | 87 | 2 | C0600519 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 1.74e-03 | 21 | 87 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | cervical squamous cell carcinoma (is_marker_for) | 1.91e-03 | 22 | 87 | 2 | DOID:3744 (is_marker_for) | |
| Disease | response to radiation | 2.27e-03 | 88 | 87 | 3 | GO_0009314 | |
| Disease | Lynch syndrome (is_implicated_in) | 2.27e-03 | 24 | 87 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | Lewy body dementia, Lewy body dementia measurement | 2.67e-03 | 26 | 87 | 2 | EFO_0006792, EFO_0006799 | |
| Disease | multisite chronic pain | 2.82e-03 | 95 | 87 | 3 | EFO_0010100 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.88e-03 | 27 | 87 | 2 | DOID:10584 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KAAAGEIIYNKCPPN | 546 | O60241 | |
| ILNKPGLKYKPVCNQ | 176 | P17516 | |
| KLHKNDYGIQPNCPA | 976 | Q9HCE0 | |
| CRLNTQPGKKVFYPV | 371 | Q8TDX6 | |
| ILNKPGLKYKPVCNQ | 176 | P42330 | |
| YPKSLQAQPVTGVKQ | 216 | Q8IWK6 | |
| INPIIYPCSSQEFKK | 321 | P35348 | |
| LCAQDNPMNPKKYLG | 246 | Q8TDX5 | |
| KCPNLTYLNLSGNKI | 86 | Q9BTT0 | |
| TYGIASVPNQPLKKQ | 461 | Q9UHI6 | |
| RYKQVKVGNCNTPKP | 71 | Q9BR61 | |
| KNLKSYFQPSPSCPQ | 391 | Q9UBZ4 | |
| KPYQPKVCENAVHGQ | 481 | P33151 | |
| VPYQSPQGILSKCLQ | 371 | Q7Z3H0 | |
| PQVPLCVSYKGEKNS | 2121 | Q14667 | |
| PPQVLRVKLCGNVKY | 31 | Q9NWR8 | |
| PEVTNYSLKGCQGKP | 141 | P10721 | |
| TKNLEKCNQPTPVRY | 326 | Q5VYY2 | |
| LCANSPRNYAKLPAK | 96 | Q8NCR3 | |
| CNLQKFPKPLPQEYQ | 441 | Q96KR4 | |
| KKPAQAPIQACLNFP | 291 | A8MWA6 | |
| LSPEICQNKPYNNKT | 171 | Q6P3R8 | |
| LEQKQKQVCAGQYGP | 156 | Q92817 | |
| AQNVKQFGTPKPCQY | 61 | Q5HYJ3 | |
| TYTPENLLNKCKPGD | 106 | Q96KN1 | |
| NPLPIYCALNTKGQS | 431 | P0C869 | |
| CNLILGNPPSKVYGN | 226 | Q9NRX1 | |
| SCKPPQYGQLETKHI | 1371 | Q7Z3U7 | |
| KKYPTCNSPKQSPIN | 51 | P23471 | |
| PLLVNCYKIPQLENK | 421 | Q9C091 | |
| LGRDPKYICQKPSIQ | 691 | Q7Z6Z7 | |
| VCQQPVYIPKKAASK | 326 | Q86Y26 | |
| APTNFPLKCQKQRGA | 331 | P0CG42 | |
| PNNLAVPLYKNGVKI | 1061 | P31327 | |
| IKQKCPLYEANGQAV | 356 | O60341 | |
| NSPGQYIQCFTVKPK | 1396 | Q14185 | |
| YIPNNKGQLIKACKT | 326 | Q99418 | |
| PKGLPVKQYAVQSQL | 91 | Q96DP5 | |
| LKQELPKYLPALQGC | 406 | Q9UQ88 | |
| DCNPNFIINGPKKIQ | 236 | Q9BXR6 | |
| CHKCPQLQYTGVQKP | 316 | Q9NS15 | |
| QCELCPLPGTAQYKK | 2421 | P35556 | |
| NPKCKSKINYGGDIP | 251 | O76054 | |
| NPKCLTKINYGGEIP | 251 | Q9UDX4 | |
| NPKCLTKINYGGEVP | 251 | Q9UDX3 | |
| NPKCLTKINYGGEVP | 251 | B5MCN3 | |
| GQAENQPYQPKGKCL | 1356 | Q9BY12 | |
| EKSLPCKVSNNNYPI | 521 | P54277 | |
| LLPQKSLSPQQYQKG | 61 | Q86WN2 | |
| YPNSLCIKVNGKLFP | 226 | O75928 | |
| KPKPQVYSTLLNSGC | 161 | Q9Y6K5 | |
| NVCFSPANKPKILAN | 2126 | Q86VV8 | |
| NPPKKANGIITQYCL | 2076 | O75445 | |
| SCQGKNYNLKVTLPG | 896 | A6NHR9 | |
| SPYAKTLQPTKQPNC | 496 | Q8N7P1 | |
| IRLQAQNNPLPKGKC | 41 | Q8TBP6 | |
| QNNPLPKGKCFVYSN | 46 | Q8TBP6 | |
| KTPPIAVQKISQYAC | 141 | P04053 | |
| KALVASLPGQLQYKC | 1381 | O95255 | |
| AYNQGLKKCPHSTPL | 731 | O94906 | |
| TPLCAILKQKAPQQY | 346 | Q9NUX5 | |
| KQVYQIVKPLNPNFC | 166 | Q9NR45 | |
| SEYKEKCFLPQNINP | 36 | Q8TF17 | |
| STKGCNVNKLNYPPF | 516 | P14410 | |
| IIKSNYQGLPLPCVK | 176 | Q96SB4 | |
| YQGLPLPCVKKIIQQ | 181 | Q96SB4 | |
| KKCAQNVQLYGTPKP | 56 | Q8TAV0 | |
| IKSNYQGLPVPCVKS | 176 | Q9UPE1 | |
| LNCKAQQKYSPVGNL | 231 | Q8N0Z2 | |
| GDSPIQKHKQLYPSC | 96 | Q13490 | |
| ILNKPGLKYKPVCNQ | 176 | Q04828 | |
| ILNKPGLKYKPVCNQ | 176 | P52895 | |
| KKILGENAKPNYGCQ | 311 | Q8N3C0 | |
| PLLLKVCNNPGLYSN | 1016 | Q15021 | |
| PYLKSKNNCQNQPPS | 36 | Q8IYA6 | |
| YLKIQPGAVPGCNNS | 501 | Q7Z2D5 | |
| KCPGNYTNPLKVQTV | 81 | Q8IY95 | |
| QSKEVPENPNYALKC | 21 | Q86VZ2 | |
| ESLQLKPGQVVYKCP | 116 | Q9NYG2 | |
| GYPLCQKKLGIVPKQ | 101 | Q8IXW5 | |
| VCKIPPGCNLKIFNN | 331 | P84022 | |
| YCNPKKIQGLELQQI | 251 | Q7Z7A4 | |
| TGNPRCQKPYFLKEI | 686 | O94813 | |
| KLLTCNGVYLNPAPG | 2016 | O00507 | |
| LEKGCSFLPDPYQKQ | 436 | P07602 | |
| YVLKPQQMCKGTFNP | 706 | Q4KWH8 | |
| KCLQIQTLLYGPQDK | 381 | Q5W5X9 | |
| CGTPNYLSPEVLNKQ | 241 | Q9NYY3 | |
| NRKVQLTYLPHGCPK | 476 | O43314 | |
| KGPLPKSYAIICNNF | 1026 | Q9BXT5 | |
| KPCPNNVEKSNRIYQ | 336 | Q9UJW2 | |
| NKPVNLYCKASPATQ | 76 | O95185 | |
| VCKQPQVYGNDIKPG | 336 | Q6ZMR5 | |
| QTKNPNYIRCIKPND | 586 | O43795 | |
| ACAKAPYTQKQVTPL | 1376 | Q6PIF6 |